Epidemiologic Study Evaluating Infections in Elderly Patients
NCT00900952
ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
- Patients > 65 years of age that are hospitalized in an Internal Medicine ward and have an active infection (skin and soft tissue, intra-abdominal, or respiratory infections) from the community that needs antibiotic treatment
- Patients must have at least one sample processed for microbiological diagnosis
- COPD exacerbation
- Urinary tract infections
- Hospital acquired infections
- Other infections not in inclusion criteria
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Chicago, Illinois
- Guangzhou, Guangdong
- Miaoli County,
- Taichung,
- Plymouth,
Descriptive Information | ||||
---|---|---|---|---|
Brief Title | Epidemiologic Study Evaluating Infections in Elderly Patients | |||
Official Title | Epidemiologic Study of Infections in Elderly Patients | |||
Brief Summary | The purpose of this observational study is to assess the prevalence and demographic and clinical characteristics of infections in elderly people admitted to Internal Medicine wards in Spain, as well as the etiology and resistance pattern for the main causal agents, and outcome. | |||
Detailed Description | Not Provided | |||
Study Type | Observational | |||
Study Design | Observational Model: Cohort Time Perspective: Prospective | |||
Target Follow-Up Duration | Not Provided | |||
Biospecimen | Not Provided | |||
Sampling Method | Non-Probability Sample | |||
Study Population | Infected elderly patients treated at Internal Medicine wards in Spanish hospitals | |||
Condition | Infection | |||
Intervention | Other: Clinical record review | |||
Study Groups/Cohorts | 1
Infected elderly patients Intervention: Other: Clinical record review | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
Recruitment Information | ||||
Recruitment Status | Completed | |||
Actual Enrollment | 240 | |||
Original Estimated Enrollment | 500 | |||
Actual Study Completion Date | June 2009 | |||
Actual Primary Completion Date | June 2009 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria | Inclusion criteria:
Exclusion criteria:
| |||
Sex/Gender |
| |||
Ages | 65 Years and older (Older Adult) | |||
Accepts Healthy Volunteers | No | |||
Contacts | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries | Spain | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number | NCT00900952 | |||
Other Study ID Numbers | 3074X1-4489 | |||
Has Data Monitoring Committee | No | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement | Not Provided | |||
Responsible Party | Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth | |||
Study Sponsor | Wyeth is now a wholly owned subsidiary of Pfizer | |||
Collaborators | Not Provided | |||
Investigators |
| |||
PRS Account | Wyeth is now a wholly owned subsidiary of Pfizer | |||
Verification Date | October 2009 |